Acute Bacterial Skin & Skin Structure Infection Market

The Acute Bacterial Skin & Skin Structure Infection Market is undergoing rapid transformation, shaped by clinical challenges, evolving therapies, and ongoing operational shifts. Senior decision-makers must navigate a complex landscape where clinical needs, regulatory changes, and commercial imperatives converge.

Market Snapshot

The acute bacterial skin and skin structure infection market grew from USD 12.35 billion in 2025 to USD 13.50 billion in 2026. It is projected to continue expanding at a CAGR of 9.02%, reaching USD 22.62 billion by 2032. This growth trajectory reflects rising infection prevalence, increased demand for rapid diagnostics, and higher investment in advanced antimicrobial therapies.

Scope & Segmentation

Product Types: Branded antibiotics, generic antibiotics, and novel agents. Generic antibiotics are detailed further into cephalosporins, lincosamides, macrolides, and penicillins, offering clarity on both overlap and unique specialist market areas.
Route of Administration: Intravenous, oral, and topical routes support differentiated care settings and patient experience needs.
End Users: Hospitals, ambulatory surgical centers, and home healthcare settings highlight shifting clinical decision pathways and channel strategies.
Distribution Channels: Hospital pharmacies, retail pharmacies, and online pharmacies ensure broad access and allow for responsive supply chain models.
Treatment Types: Empiric and targeted treatments, with targeted approaches separated into culture-guided and PCR-guided regimens to emphasize the influence of diagnostic specificity on product uptake.
Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific, each reflecting unique regulatory, operational, and access priorities.
Technologies: Rapid diagnostics and antimicrobial stewardship programs play a critical role in shaping prescribing behaviors and advancing clinical innovation.

Key Takeaways

Decision-making in acute bacterial skin and skin structure infection care hinges on clinical urgency, effective antimicrobial stewardship, and innovative therapy options.
Transition of care from inpatient settings to ambulatory and home healthcare increases the importance of flexible drug administration methods, requiring adaptive distribution solutions.
Stakeholders face evolving regulatory frameworks and reimbursement models, necessitating dynamic product positioning and market entry strategies.
Partnerships between pharmaceutical companies, diagnostic firms, and home healthcare providers enable integrated solutions tailored to specific care settings.
Companies that leverage segmentation intelligence and align diagnostic partnerships with evidence-based value propositions improve adoption and generate sustainable competitive advantages.

Tariff Impact Across the U.S. Health Ecosystem

Tariff introductions in 2025 led to notable increases in costs for imported pharmaceuticals, compelling manufacturers and distributors to enhance supply chain resilience. Strategies include supplier diversification, regional sourcing, and greater inventory transparency. Hospitals and retail networks adjusted procurement practices to manage operational costs while ensuring uninterrupted access to essential agents. These shifts drove deeper collaboration across commercial, regulatory, and supply chain teams to maintain therapeutic availability and balance operational resilience with medium-term cost controls.

Methodology & Data Sources

This report utilizes a mixed-methods approach, combining in-depth interviews with clinicians, pharmacy directors, and care leaders alongside a synthesis of peer-reviewed literature, treatment guidelines, regulatory documentation, and public policy data. Analytical frameworks include segmentation, trend mapping, scenario analysis, and sensitivity reviews. Findings have been validated with both independent clinical experts and commercial leaders, ensuring actionable and real-world insights.

Why This Report Matters

Offers a comprehensive, segmented view of the acute bacterial skin and skin structure infection market, directly addressing both clinical and commercial decision drivers.
Informs strategic planning by clarifying product, distribution, and diagnostic alignment across key geographies and care settings.
Enables operational teams to respond proactively to regulatory, market, and supply chain shifts that impact product adoption and stakeholder engagement.

Conclusion

The acute bacterial skin and skin structure infection market demands coordinated action across clinical, supply chain, and commercial functions. Leaders who align diagnostic innovation, adaptive sourcing, and channel enablement are best positioned for sustainable growth and patient-centered outcomes.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Acute Bacterial Skin & Skin Structure Infection Market, by Product Type

8.1. Branded Antibiotics
8.2. Generic Antibiotics
8.2.1. Cephalosporins
8.2.2. Lincosamides
8.2.3. Macrolides
8.2.4. Penicillins
8.3. Novel Agents

9. Acute Bacterial Skin & Skin Structure Infection Market, by Route Of Administration

9.1. Intravenous
9.2. Oral
9.3. Topical

10. Acute Bacterial Skin & Skin Structure Infection Market, by End User

10.1. Ambulatory Surgical Centers
10.2. Home Healthcare Settings
10.3. Hospitals

11. Acute Bacterial Skin & Skin Structure Infection Market, by Distribution Channel

11.1. Hospital Pharmacies
11.2. Online Pharmacies
11.3. Retail Pharmacies

12. Acute Bacterial Skin & Skin Structure Infection Market, by Treatment Type

12.1. Empiric Treatment
12.2. Targeted Treatment
12.2.1. Culture Guided
12.2.2. Pcr Guided

13. Acute Bacterial Skin & Skin Structure Infection Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Acute Bacterial Skin & Skin Structure Infection Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Acute Bacterial Skin & Skin Structure Infection Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Acute Bacterial Skin & Skin Structure Infection Market
17. China Acute Bacterial Skin & Skin Structure Infection Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc
18.6. Basilea Pharmaceutica Ltd
18.7. Bayer AG
18.8. Cipher Pharmaceuticals Inc
18.9. Cipla Limited
18.10. Cumberland Pharmaceuticals Inc
18.11. Dr. Reddy's Laboratories Ltd
18.12. GlaxoSmithKline plc
18.13. Glenmark Pharmaceuticals Ltd
18.14. Lupin Limited
18.15. Melinta Therapeutics LLC
18.16. Menarini Group
18.17. Merck & Co. Inc
18.18. Nabriva Therapeutics plc
18.19. Novartis AG
18.20. Paratek Pharmaceuticals Inc
18.21. Pfizer Inc
18.22. Teva Pharmaceutical Industries Ltd
18.23. Viatris Inc
18.24. Zydus Lifesciences Limited

List of Figures

FIGURE 1. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY BRANDED ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY BRANDED ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY BRANDED ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY CEPHALOSPORINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY CEPHALOSPORINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY LINCOSAMIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY LINCOSAMIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY LINCOSAMIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY NOVEL AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY NOVEL AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY NOVEL AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY EMPIRIC TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY EMPIRIC TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY EMPIRIC TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY CULTURE GUIDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY CULTURE GUIDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY CULTURE GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PCR GUIDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PCR GUIDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PCR GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 102. EUROPE ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. EUROPE ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 104. EUROPE ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 105. EUROPE ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. EUROPE ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. EUROPE ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 118. AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 121. AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 122. AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 124. AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 125. AFRICA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. ASEAN ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. ASEAN ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASEAN ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 138. ASEAN ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. ASEAN ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. ASEAN ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. ASEAN ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 142. ASEAN ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 143. GCC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GCC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. GCC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 146. GCC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 147. GCC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. GCC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. GCC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 150. GCC ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 159. BRICS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. BRICS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 161. BRICS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 162. BRICS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. BRICS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. BRICS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. BRICS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 166. BRICS ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 167. G7 ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. G7 ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 169. G7 ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 170. G7 ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. G7 ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. G7 ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. G7 ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 174. G7 ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 175. NATO ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. NATO ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. NATO ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 178. NATO ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 179. NATO ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. NATO ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. NATO ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 182. NATO ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)
TABLE 192. CHINA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 193. CHINA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. CHINA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY GENERIC ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 195. CHINA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 196. CHINA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. CHINA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. CHINA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 199. CHINA ACUTE BACTERIAL SKIN & SKIN STRUCTURE INFECTION MARKET SIZE, BY TARGETED TREATMENT, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Acute Bacterial Skin & Skin Structure Infection market report include:

AbbVie Inc
Basilea Pharmaceutica Ltd
Bayer AG
Cipher Pharmaceuticals Inc
Cipla Limited
Cumberland Pharmaceuticals Inc
Dr. Reddy's Laboratories Ltd
GlaxoSmithKline plc
Glenmark Pharmaceuticals Ltd
Lupin Limited
Melinta Therapeutics LLC
Menarini Group
Merck & Co. Inc
Nabriva Therapeutics plc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Viatris Inc
Zydus Lifesciences Limited

Table Information

Report Attribute	Details
No. of Pages	186
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 13.5 Billion
Forecasted Market Value ( USD ) by 2032	$ 22.62 Billion
Compound Annual Growth Rate	9.0%
Regions Covered	Global
No. of Companies Mentioned	20

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3513EUR$3,939USD£3,047GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3789EUR$4,249USD£3,286GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5136EUR$5,759USD£4,454GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6215EUR$6,969USD£5,390GBP

Acute Bacterial Skin & Skin Structure Infection Market - Global Forecast 2026-2032

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact Across the U.S. Health Ecosystem

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact Across the U.S. Health Ecosystem

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Acute Bacterial Skin and Skin Structure Infections - Global Strategic Business Report

Acute Bacterial Skin and Skin Structure Infections (ABSSIs) Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Acute Bacterial Skin and Skin Structure Infections Market Report 2025

Acute Bacterial Skin and Skin Structure Infection Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

Complicated Skin and Skin Structure Infections Drugs Market Report 2025